Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

• Main Authors: Xuemei Yang (Author), Jialing Sun (Author), Bin Wen (Author), Yu Wang (Author), Mingjia Zhang (Author), Weicong Chen (Author), Wenting Zhao (Author), Chunyu He (Author), Xiaodan Zhong (Author), Yang Liu (Author), Tong Li (Author), Haitao Sun (Author), Songqi He (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tumor-infiltrating CD8+T lymphocytes are mostly associated with a favorable prognosis in numerous cancers, including hepatocellular carcinoma (HCC). Biejiajian Pill (BJJP) is a common type of traditional Chinese medicine that is widely used in the treatment of HCC in China. Previous studies showed t...